Publicacions en col·laboració amb investigadors/es de Centro Nacional de Investigaciones Oncológicas (9)

2022

  1. Distinct roles for PARP-1 and PARP-2 in c-Myc–driven B-cell lymphoma in mice

    Blood, Vol. 139, Núm. 2, pp. 228-239

  2. Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis

    eBioMedicine, Vol. 75

2014

  1. Cdk4 and Cdk6 cooperate in counteracting the INK4 family of inhibitors during murine leukemogenesis

    Blood, Vol. 124, Núm. 15, pp. 2380-2390

2012

  1. Crystal structure of inhibitor of growth 4 (ING4) dimerization domain reveals functional organization of ING family of chromatin-binding proteins

    Journal of Biological Chemistry, Vol. 287, Núm. 14, pp. 10876-10884

2010

  1. Corrigendum to "Solution structure and NMR characterization of the binding to methylated histone tails of the plant homeodomain finger of the tumour suppressor ING4" [FEBS Lett. 580 (2006) 6903-6908] (DOI:10.1016/j.febslet.2006.11.055)

    FEBS Letters

  2. Crystallization and preliminary X-ray diffraction analysis of the dimerization domain of the tumour suppressor ING4

    Acta Crystallographica Section F: Structural Biology and Crystallization Communications, Vol. 66, Núm. 5, pp. 567-570

  3. The dimeric structure and the bivalent recognition of H3K4me3 by the tumor suppressor ING4 suggests a mechanism for enhanced targeting of the HBO1 complex to chromatin

    Journal of Molecular Biology, Vol. 396, Núm. 4, pp. 1117-1127

2008

  1. Molecular basis of histone H3K4me3 recognition by ING4

    Journal of Biological Chemistry, Vol. 283, Núm. 23, pp. 15956-15964

2006

  1. Solution structure and NMR characterization of the binding to methylated histone tails of the plant homeodomain finger of the tumour suppressor ING4

    FEBS Letters, Vol. 580, Núm. 30, pp. 6903-6908